Sandu Pharmaceuticals is trading 4.39% upper at Rs 52.80 as compared to its last closing price. Sandu Pharmaceuticals has been trading in the price range of 53.98 & 50.58. Sandu Pharmaceuticals has given -6.86% in this year & 1.23% in the last 5 days. Sandu Pharmaceuticals has TTM P/E ratio 18.25 as compared to the sector P/E of 50.75.The company posted a net profit of 0.50 Crores in its last quarter.Listed peers of Sandu Pharmaceuticals include Deccan Health Care (-1.98%), Roopa Industries (0.89%), Sandu Pharmaceuticals (4.39%).The Mutual Fund holding in Sandu Pharmaceuticals was at -% in . The MF holding has - from the last quarter. The FII holding in Sandu Pharmaceuticals was at -% in . The FII holding has - from the last quarter.
Updated on Feb 16, 2025, 09:52 PM UTC
|
|
|
|
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
---|---|---|---|---|---|---|---|---|
Deccan Health Care | Bearish | 23.78 | -1.98 | 53.90 | 29.50 | 0.5 | - | 1.73 |
Roopa Industries | Bearish | 66.83 | 0.89 | 52.57 | 34.60 | 3.4 | - | 34.12 |
Sandu Pharmaceuticals | Moderately Bearish | 52.80 | 4.39 | 51.01 | 35.26 | 1.27 | 1.50 | 0.15 |
ANG Lifesciences India | Bearish | 38.00 | -1.91 | 49.62 | - | 0.65 | - | 21.92 |
Chandra Bhagat Pharma | Bearish | 63.05 | -4.35 | 47.57 | 29.95 | 1.64 | - | 4.87 |
Meeting Date | Purpose |
---|---|
2025-02-13 | Quarterly Results |
2024-11-14 | Quarterly Results |
2024-08-12 | Quarterly Results & Final Dividend |
2024-06-05 | Audited Results |
2024-05-30 | Audited Results |
Sandu Pharmaceuticals is trading at 52.80 as on Fri Feb 14 2025 09:52:41. This is 4.39% upper as compared to its previous closing price of 50.58.
The market capitalization of Sandu Pharmaceuticals is 51.01 Cr as on Fri Feb 14 2025 09:52:41.
The 52 wk high for Sandu Pharmaceuticals is 85.00 whereas the 52 wk low is 49.50
Sandu Pharmaceuticals can be analyzed on the following key metrics -
Sandu Pharmaceuticals reported a net profit of 1.46 Cr in 2024.